Special Issue "Cell Therapy"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (15 November 2014)
Prof. Dr. Shin Mineishi
Bone Marrow Transplant Program, Penn State Hershey Medical Center, 500 University Drive, P.O Box 850, Hershey, PA 17033, USA
Website | E-Mail
Interests: bone marrow transplantation; graft versus host disease; complications after stem cell transplantation; reduced intensity stem cell transplantation; HLA-mismatch stem cell transplantation; graft engineering; cell therapy; and gene therapy
The journal Pharmaceuticals will be publishing a Special Issue covering the topic “Cell Therapy” and I am cordially inviting you to contribute an article to this volume. This is a timely issue as cell therapy has recently evolved from laboratory research/animal models into clinical trials showing promising results.
Cell therapy covers a wide variety of research, from proof of principle experiments to clinical cell transplant/cell therapy, including immune cell therapy, vaccine therapy, gene therapy, and others. Most of the area may belong to either cancer cell therapy or regenerative medicine. For this issue, I would like to invite manuscript submissions from authors engaged in a wide variety of projects in order to meet the needs of interested readers from various backgrounds.
I hope this issue facilitates discussions among investigators in the many different areas of cell therapy which may lead to further steps in the pertinent investigations.
Prof. Dr. Shin Mineishi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 850 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cell therapy
- cell transplant
- immune cell therapy
- vaccine therapy
- gene therapy
- cancer cell therapy
- regenerative medicine